692058-52-9

Basic information

• Product Name: (3aR,6aS)-rel-tetrahydro-4H-1,3-Dioxolo[4,5-c]pyrrole hydrochloride (Relative struc)
• Synonyms: (3aR,6aS)-rel-tetrahydro-4H-1,3-Dioxolo[4,5-c]pyrrole hydrochloride (Relative struc)
• CAS NO: 692058-52-9
• Molecular Formula: C5H10ClNO2
• Molecular Weight: 151.59
• Mol File: 692058-52-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (3aR,6aS)-rel-tetrahydro-4H-1,3-Dioxolo[4,5-c]pyrrole hydrochloride (Relative struc)(CAS DataBase Reference)
• NIST Chemistry Reference: (3aR,6aS)-rel-tetrahydro-4H-1,3-Dioxolo[4,5-c]pyrrole hydrochloride (Relative struc)(692058-52-9)
• EPA Substance Registry System: (3aR,6aS)-rel-tetrahydro-4H-1,3-Dioxolo[4,5-c]pyrrole hydrochloride (Relative struc)(692058-52-9)

Safety Data

• Hazardous Substances Data: 692058-52-9(Hazardous Substances Data)

Upstream product

• 612501-78-7 tert-butyl tetrahydro-5H-[1,3]dioxolo[4,5-c]pyrrole-5-carboxylate 
• 612501-78-7 tert-butyl (3RS,4SR)-3,4-methylenedioxypyrrolidine-1-carboxylate 
• 694439-01-5 tert-butyl (3RS,4SR)-3,4-methylenedioxypyrrolidine-1-carboxylate 

Downstream Products

• 728862-98-4 (3RS,4SR)-3,4-methylenedioxypyrrolidine 
• 692058-31-4 (3RS,4SR)-3,4-methylenedioxypyrrolidine 
• 667461-56-5 2-[(3aR,6aS)-tetrahydro-5H-[1,3]dioxolo[4,5-c]pyrrol-5-yl]-ethanol 

Relevant articles and documents

QUINAZOLINE DERIVATIVE AS ANGIOGENESIS INHIBITORS

-

QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS

The invention concerns quinazoline derivatives of Formula (I): (A chemical formula should be inserted here - please see paper copy enclosed herewith) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)2 group wherein each R2 group is hydrogen or (1-8C) alkyl, m is 0, 1, 2 or 3, each R1 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, n is 0, 1, 2 or 3, and each R3 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, or pharmaceutically-acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.